Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:
“I was very delighted to have been invited to HKSTP – Hong Kong Science and Technology Parks Corporation’s recent event Fireside Chat: From Clinical Trials to Fundraising, Licensing Deals and Acquisitions.
This provided an opportunity for me as a Clinician Investigator to showcase how we are in a good position to leverage on strategic advantages of Hong Kong in order to benefit the drug development ecosystem in the Greater Bay Area, China and the rest of the Asia Pacific Region.
Lots of excellent speakers representing various stakeholders in this ecosystem. Thanks HKSTP for organising this event!”
Other articles featuring Herbert Loong on OncoDaily.
